🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiparametric MRI of the prostate (mpMRI) plays an integral role in conte...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-02-28
Trial ID
NCT05046782
Treatments Being Tested
This study will examine if MRI perfusion and PET/CT can tell growing tumor ...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2012-05
Trial ID
NCT01604512
Treatments Being Tested
The detection and delineation of the intraprostatic tumor burden plays a cr...
Status
Recruiting
Location
German Oncology Center
Start Date
2025-08-18
Trial ID
NCT07568613
Treatments Being Tested
This is a multicenter, multinational trial to evaluate advanced MRI techniq...
Status
Recruiting
Location
University of California San Diego
Start Date
2023-12-15
Trial ID
NCT06579417
Treatments Being Tested
This study is looking at a breast cancer screening technique, restriction s...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2018-04-18
Trial ID
NCT03495115
This single-center study will enroll 40 male participants to complete 2 dif...
Status
Recruiting
Location
UCSD Moores Cancer Center
Start Date
2021-11-02
Trial ID
NCT04992728
Treatments Being Tested
This study aims to learn how to improve MRIs (Magnetic Resonance Imaging) t...
Status
Unknown
Location
UC San Diego Moores Cancer Center
Start Date
2016-03-24
Trial ID
NCT03440554
Treatments Being Tested
Adult male patients with high-risk, localized prostate cancer and planning ...
Status
Active Not Recruiting
Location
UCSD Moores Cancer Center
Start Date
2020-12-29
Trial ID
NCT04349501
Treatments Being Tested
The researchers hope to learn if specific types of MRI software and techniq...
Status
Recruiting
Location
University of California, San Diego
Start Date
2023-12-04
Trial ID
NCT05882253
Treatments Being Tested